Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HVI vs ACP in Chronic Achilles Tendinopathy
NCT02417987Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- May 2012
- Primary completion
- Aug 2014
- Modality
- Adipose-derived MSCs, Orthosteric Ligands, Bone Marrow MSCs
01
Overview
Randomised, double-blind trial of autologous conditioned plasma, bupivacaine and methylprednisolone in Achilles tendinopathy (3 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Victorian Institute of Sports Assessment-Achilles at 24 weeks. Started May 2012; status: completed.
02
Drugs
autologous conditioned plasmabupivacainemethylprednisolone
03
Conditions
Achilles tendinopathy
Beyond the preview
Go deeper on NCT02417987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02417987.